GC Biopharma and Speragen Sponsored an Externally Led - Patient Focused Drug Development with FDA Attendance
/PRNewswire/ -- GC Biopharma (006280.KS) and Speragen today announced that a joint Externally Led - Patient-Focused Drug Development (EL-PFDD) meeting hosted...
Source: prnewswire.com